C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C07H 21/00 (2006.01) C40B 30/04 (2006.01)
Patent
CA 2701202
Methods of determining the risk of ASD in an individual are provided which comprise identifying the presence of one or more genomic mutations in one or more of the genes, PTCHDI, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 and FTSJ1.
L'invention porte sur des procédés de détermination du risque de TSA chez un individu. Ces procédés comprennent l'identification de la présence d'une ou de plusieurs mutations génomiques dans un ou plusieurs des gènes PTCHD1, SHANK3, NFIA, DPP6, DPP10, DYPD, GPR98, PQBP1, ZNF41 et FTSJ1.
Scherer Stephen W.
Vincent John B.
Centre For Addiction And Mental Health
Gowling Lafleur Henderson Llp
The Hospital For Sick Children
LandOfFree
Biomarkers for autism spectrum disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers for autism spectrum disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for autism spectrum disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1973499